Financial Performance - The company's revenue for Q1 2025 reached ¥142,218,693.32, representing a 28.23% increase compared to ¥110,910,882.85 in the same period last year[3] - Net profit attributable to shareholders was ¥16,640,986.05, a significant increase of 288.73% from ¥4,280,819.84 year-on-year[3] - The net profit excluding non-recurring gains and losses was ¥13,272,020.92, reflecting a 455.51% increase compared to ¥2,389,180.90 in the previous year[3] - Basic and diluted earnings per share were both ¥0.3167, up 290.51% from ¥0.0811 in the same period last year[3] - Total operating revenue for Q1 2025 reached CNY 142.22 million, representing a year-on-year growth of 28.23%[14] - Gross margin for Q1 2025 was 50.49%, an increase of 1.01 percentage points year-on-year[14] - Net profit for Q1 2025 was ¥16.64 million, compared to ¥4.28 million in Q1 2024, representing a 288.5% increase[21] - Earnings per share for Q1 2025 were ¥0.3167, significantly higher than ¥0.0811 in Q1 2024[22] Research and Development - Research and development expenses totaled ¥19,661,251.28, which is 12.20% higher than ¥17,523,425.37 in the previous year[3] - Research and development expenses for Q1 2025 amounted to ¥19.66 million, an increase from ¥17.52 million in Q1 2024[21] - The proportion of R&D expenses to revenue decreased to 13.82%, down by 1.98 percentage points from 15.80%[4] - The company is currently developing new products for major clients in the biometric recognition sector, which has seen a decline in demand for existing designs[14] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,494,178,981.73, a 2.30% increase from ¥1,460,566,903.73 at the end of the previous year[4] - The company's total assets as of March 31, 2025, were CNY 1.14 billion, reflecting a stable financial position[16] - Total liabilities increased to ¥303.78 million from ¥288.84 million, reflecting a growth of 5.4%[18] - The company's equity attributable to shareholders rose to ¥1,190.40 million, compared to ¥1,171.73 million in the previous year[18] Cash Flow - The company reported a net cash flow from operating activities of -¥12,844,263.58, an improvement from -¥33,083,910.65 in the same period last year[3] - Cash inflow from operating activities for Q1 2025 was $145,737,696.62, an increase of 32% compared to $110,383,707.85 in Q1 2024[24] - Net cash outflow from operating activities for Q1 2025 was -$12,844,263.58, an improvement from -$33,083,910.65 in Q1 2024[25] - The cash flow from operating activities for Q1 2025 showed a positive trend, indicating improved liquidity[23] - The ending balance of cash and cash equivalents for Q1 2025 was $279,040,317.63, down from $508,484,302.21 in Q1 2024[26] Shareholder Information - The top shareholder, Nanjing Maolai Holdings Co., Ltd., holds 59.47% of the shares, with no shares pledged or frozen[9] Future Plans - The company plans to issue convertible bonds to unspecified investors, with related proposals approved in board meetings held in January and April 2025[13] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[19] Market and Sector Performance - Semiconductor sector accounted for 63.51% of total revenue, with significant growth also seen in life sciences and medical sectors[14] - Total operating costs for Q1 2025 were ¥121.26 million, up 16.0% from ¥104.48 million in Q1 2024[20] - The company did not report any new product launches or significant market expansion strategies during the conference call[24]
茂莱光学(688502) - 2025 Q1 - 季度财报